{"id":848956,"date":"2025-05-08T07:10:04","date_gmt":"2025-05-08T11:10:04","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/"},"modified":"2025-05-08T07:10:04","modified_gmt":"2025-05-08T11:10:04","slug":"clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/","title":{"rendered":"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ALPHARETTA, Ga., May  08, 2025  (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD) (\u201cClearside\u201d or the \u201cCompany\u201d), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS<sup>\u00ae<\/sup>), announced today that its first quarter 2025 financial results will be reported on Wednesday, May 14, 2025 after the close of the financial markets. The Company will not be hosting a conference call this quarter.<\/p>\n<p align=\"justify\">Information about the Company\u2019s quarterly results, conference calls, webcasts and other investor information is available in the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=8GdMRc8lIqLhzvjyrw_oub_V6g7Dz5xjkHPAvsRKRVbGuXVr4aFEMAy5KQ3BeT2QTWLYdhG5qO1GDUfMnykukz7Pl92SIFAuwA6cu5BC3owrK67L39hbbFSPdVdwJQ_S\" rel=\"nofollow\" target=\"_blank\">Investors<\/a> section of the Company\u2019s website.<\/p>\n<p align=\"justify\">\n        <strong>About Clearside Biomedical, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS<sup>\u00ae<\/sup>) to improve patient outcomes. Clearside\u2019s SCS injection platform, utilizing the Company\u2019s patented SCS Microinjector<sup>\u00ae<\/sup>, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases. Clearside is developing its own pipeline of small molecule product candidates for administration via its SCS Microinjector. The Company\u2019s lead program, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=X0UE5lQipw0_X4gRweveY1ry2SKpSk15CFvbzEcm9GZmzNO0DofSsbd9oa2nnMcsMi3n2jSHe_HwKdJlqWeBqz2Ya5je2_GYxCGf1xpIegNKvsP_sJCADgEyI1WcZp7Ix4zIGXRDKGv05AveUb1bfw==\" rel=\"nofollow\" target=\"_blank\">CLS-AX (axitinib injectable suspension)<\/a>, is in development for the treatment of neovascular age-related macular degeneration (wet AMD). Planning for a Phase 3 program is underway. In addition, Clearside is evaluating various small molecules for the potential long-acting treatment of geographic atrophy (GA). Clearside developed and gained approval for its first product, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=cDgF65bPcBbLT5vhl_cXnoKf_HPi9ZgXRUYx1yrrC7xEpqWW6CQdgrEcO13a_LStLeMfMJAyoqm1uuxMZDP8F8VajNe-jrLfPf8uRlMnYzxmQDg-J2HryY86xppiTiZgEC6e4GlJNbd7ow41MDdhXe1AsaSn0BnwwG8PCT92i48=\" rel=\"nofollow\" target=\"_blank\">XIPERE<sup>\u00ae<\/sup> (triamcinolone acetonide injectable suspension)<\/a> for suprachoroidal use, which is available in the U.S. through a commercial partner. Clearside also strategically partners its SCS injection platform with companies utilizing other ophthalmic therapeutic innovations. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=EHKXvSIHyCSMGA8UroHsDlzfULQFeYVTh7Pa725wj9cZGh2aeXWLAfa0B4yWMfXRb0JhDxdnswUlKUaxyWY5JEFunocqf09_KqxIbGRO3Tw=\" rel=\"nofollow\" target=\"_blank\">clearsidebio.com<\/a> or follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VK-qm_Y6hpjxhbS2IcNQ1-ihpvgEOL5DOB7o4WTbU78MqdjUjKBEtwhG4CXHlrBIqoEPzUnAB9Up_SSte7HEhqnbcaWWDJteBOwKicuTJUeITeKXNPM2gAn5t66mTAP5\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=z68lroQ_9ar5RqnIox805a9Yvphdzt8F9Q2FkxnENbZtB0JFlX_6WmKqITGQ-NXoYmMq1SVV1aoML7pKeAi_GA==\" rel=\"nofollow\" target=\"_blank\">X<\/a>.<\/p>\n<p>\n        <strong>Investor and Media Contacts:<\/strong><\/p>\n<p>Jenny Kobin <br \/>Remy Bernarda <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xf359FDWsDSoRbZl8Y37prrCqFJ5FEJ1BzO9sD0KB1VW_D1qkwcqfsZDdb5nmruHCOwSz-92bFjFY4abeBctvYoVAXkGoIRoLpQx9MUmFDA=\" rel=\"nofollow\" target=\"_blank\">ir@clearsidebio.com<\/a><\/p>\n<p>Source: Clearside Biomedical, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTJlNWMzNDktNTNiYS00MmNmLWFiYTctZWNmYzNiZjkyYjQ0LTEwMjI3MzUtMjAyNS0wNS0wOC1lbg==\/tiny\/Clearside-Biomedical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD) (\u201cClearside\u201d or the \u201cCompany\u201d), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae), announced today that its first quarter 2025 financial results will be reported on Wednesday, May 14, 2025 after the close of the financial markets. The Company will not be hosting a conference call this quarter. Information about the Company\u2019s quarterly results, conference calls, webcasts and other investor information is available in the Investors section of the Company\u2019s website. About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-848956","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD) (\u201cClearside\u201d or the \u201cCompany\u201d), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae), announced today that its first quarter 2025 financial results will be reported on Wednesday, May 14, 2025 after the close of the financial markets. The Company will not be hosting a conference call this quarter. Information about the Company\u2019s quarterly results, conference calls, webcasts and other investor information is available in the Investors section of the Company\u2019s website. About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae) &hellip; Continue reading &quot;Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-08T11:10:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025\",\"datePublished\":\"2025-05-08T11:10:04+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/\"},\"wordCount\":316,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/\",\"name\":\"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=\",\"datePublished\":\"2025-05-08T11:10:04+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/","og_locale":"en_US","og_type":"article","og_title":"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Market Newsdesk","og_description":"ALPHARETTA, Ga., May 08, 2025 (GLOBE NEWSWIRE) &#8212; Clearside Biomedical, Inc.\u00a0(Nasdaq: CLSD) (\u201cClearside\u201d or the \u201cCompany\u201d), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae), announced today that its first quarter 2025 financial results will be reported on Wednesday, May 14, 2025 after the close of the financial markets. The Company will not be hosting a conference call this quarter. Information about the Company\u2019s quarterly results, conference calls, webcasts and other investor information is available in the Investors section of the Company\u2019s website. About Clearside Biomedical, Inc. Clearside Biomedical, Inc. is a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS\u00ae) &hellip; Continue reading \"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-08T11:10:04+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025","datePublished":"2025-05-08T11:10:04+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/"},"wordCount":316,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/","name":"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=","datePublished":"2025-05-08T11:10:04+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ0NzAxNSM2OTI4Mjc5IzIwMTExNjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/clearside-biomedical-to-report-first-quarter-2025-financial-results-on-wednesday-may-14-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Clearside Biomedical to Report First Quarter 2025 Financial Results on Wednesday, May 14, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/848956","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=848956"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/848956\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=848956"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=848956"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=848956"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}